Paul A. Barsanti,Cheng Hu,Cheng Hu,Keith B. Pfister,Martin Sendzik,James Sutton
申请号:
US13393457
公开号:
US20120165306A1
申请日:
2010.09.02
申请国别(地区):
US
年份:
2012
代理人:
摘要:
The present invention provides a compound of Formula (I):and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor.